Search Results - "Yanagimura N"

O17-5 Clinical impact of 18F-FDG-PET/CT in predicting ICI-induced ILD in patients with lung cancer.

Authors: Watanabe, S. Yamazaki, M. Yanagimura, N. et al.

Source: Annals of Oncology. Oct2024:Supplement 3, Vol. 35, pS1325-S1325. 1p.

Nintedanib enhances the antitumor efficacy of pd-1 blockade, potentially through inhibition of myeloid-derived suppressor cells and cancer-associated fibroblasts.

Authors: Suzuki R Watanabe S Shono K et al.

Source: Cancer immunology, immunotherapy : CII [Cancer Immunol Immunother] 2026 Mar 05; Vol. 75 (4). Date of Electronic Publication: 2026 Mar 05.

Publication Type: Journal Article

Journal Info: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 8605732 Publication Model: Electronic Cited Medium: Internet ISSN: 1432-0851 (Electronic) Linking ISSN: 03407004 NLM ISO Abbreviation: Cancer Immunol Immunother Subsets: MEDLINE

Sarcomatoid Transformation of Pulmonary Mucinous Adenocarcinoma as a Mechanism of Immunotherapy Resistance.

Authors: Yanai K Tanaka T Kimura K et al.

Source: Thoracic cancer [Thorac Cancer] 2026 Jun; Vol. 17 (12), pp. e70327.

Publication Type: Case Reports; Journal Article

Journal Info: Publisher: Wiley Publishing Asia Pty Ltd Country of Publication: Singapore NLM ID: 101531441 Publication Model: Print Cited Medium: Internet ISSN: 1759-7714 (Electronic) Linking ISSN: 17597706 NLM ISO Abbreviation: Thorac Cancer Subsets: MEDLINE

Anti-cancer therapy and the exacerbation of pulmonary nontuberculous mycobacterial infection.

Authors: Tanaka T Yanagimura N Arita M et al.

Source: Respiratory investigation [Respir Investig] 2026 May 19; Vol. 64 (4), pp. 101451. Date of Electronic Publication: 2026 May 19.

Publication Type: Journal Article

Journal Info: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 101581124 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2212-5353 (Electronic) Linking ISSN: 22125345 NLM ISO Abbreviation: Respir Investig Subsets: MEDLINE

Muscle loss and pentraxin-3 as predictors of immunotherapy outcomes in non-small cell lung cancer: a prospective study.

Authors: Masuda T Watanabe S Suzuki R et al.

Source: Scientific reports [Sci Rep] 2026 May 06. Date of Electronic Publication: 2026 May 06.

Publication Type: Journal Article

Journal Info: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2045-2322 (Electronic) Linking ISSN: 20452322 NLM ISO Abbreviation: Sci Rep Subsets: MEDLINE

Successful treatment with tepotinib followed by pembrolizumab in pulmonary pleomorphic carcinoma harbouring a MET exon 14 skipping mutation: A case report.

Authors: Tanaka S Saida Y Ando Y et al.

Source: Oncology letters [Oncol Lett] 2026 Feb 12; Vol. 31 (4), pp. 138. Date of Electronic Publication: 2026 Feb 12 (Print Publication: 2026).

Publication Type: Case Reports; Journal Article

Journal Info: Publisher: Spandidos Publications] Country of Publication: Greece NLM ID: 101531236 Publication Model: eCollection Cited Medium: Internet ISSN: 1792-1082 (Electronic) Linking ISSN: 17921074 NLM ISO Abbreviation: Oncol Lett Subsets: PubMed not MEDLINE

Risk of lung injury with immune checkpoint inhibitors after talc pleurodesis: A retrospective study.

Authors: Tanaka S Nozaki K Watanabe S et al.

Source: Lung cancer (Amsterdam, Netherlands) [Lung Cancer] 2025 Jun; Vol. 204, pp. 108590. Date of Electronic Publication: 2025 May 21.

Publication Type: Journal Article

Journal Info: Publisher: Elsevier Scientific Publishers Country of Publication: Ireland NLM ID: 8800805 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1872-8332 (Electronic) Linking ISSN: 01695002 NLM ISO Abbreviation: Lung Cancer Subsets: MEDLINE

The diagnostic value of comprehensive next-generation sequencing for genetic mutations in suspected lung cancer cases with negative pathological cytology.

Authors: Goto Y Watanabe S Yanagimura N et al.

Source: Lung cancer (Amsterdam, Netherlands) [Lung Cancer] 2025 Apr; Vol. 202, pp. 108505. Date of Electronic Publication: 2025 Mar 18.

Publication Type: Journal Article; Observational Study; Multicenter Study

Journal Info: Publisher: Elsevier Scientific Publishers Country of Publication: Ireland NLM ID: 8800805 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1872-8332 (Electronic) Linking ISSN: 01695002 NLM ISO Abbreviation: Lung Cancer Subsets: MEDLINE

¹⁸F-FDG-PET/CT Uptake by Noncancerous Lung as a Predictor of Interstitial Lung Disease Induced by Immune Checkpoint Inhibitors.

Authors: Yamazaki M Watanabe S Tominaga M et al.

Source: Academic radiology [Acad Radiol] 2025 Feb; Vol. 32 (2), pp. 1026-1035. Date of Electronic Publication: 2024 Sep 02.

Publication Type: Journal Article

Journal Info: Publisher: Association Of University Radiologists Country of Publication: United States NLM ID: 9440159 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-4046 (Electronic) Linking ISSN: 10766332 NLM ISO Abbreviation: Acad Radiol Subsets: MEDLINE

Authors' Response: FDG-PET/CT in Lung: Beyond Cancer.

Authors: Yamazaki M Watanabe S Tominaga M et al.

Source: Academic radiology [Acad Radiol] 2025 Feb; Vol. 32 (2), pp. 1156. Date of Electronic Publication: 2024 Nov 18.

Publication Type: Letter

Journal Info: Publisher: Association Of University Radiologists Country of Publication: United States NLM ID: 9440159 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-4046 (Electronic) Linking ISSN: 10766332 NLM ISO Abbreviation: Acad Radiol Subsets: MEDLINE; In Process

Inhibition of EGFR and MEK surmounts entrectinib resistance in a brain metastasis model of NTRK1-rearranged tumor cells.

Authors: Suzuki C Nishiyama A Arai S et al.

Source: Cancer science [Cancer Sci] 2022 Jul; Vol. 113 (7), pp. 2323-2335. Date of Electronic Publication: 2022 May 11.

Publication Type: Journal Article

Journal Info: Publisher: Wiley Publishing on behalf of the Japanese Cancer Association Country of Publication: England NLM ID: 101168776 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1349-7006 (Electronic) Linking ISSN: 13479032 NLM ISO Abbreviation: Cancer Sci Subsets: MEDLINE

STAT3 inhibition suppresses adaptive survival of ALK-rearranged lung cancer cells through transcriptional modulation of apoptosis.

Authors: Yanagimura N Takeuchi S Fukuda K et al.

Source: NPJ precision oncology [NPJ Precis Oncol] 2022 Feb 28; Vol. 6 (1), pp. 11. Date of Electronic Publication: 2022 Feb 28.

Publication Type: Journal Article

Journal Info: Publisher: Springer Nature Country of Publication: England NLM ID: 101708166 Publication Model: Electronic Cited Medium: Print ISSN: 2397-768X (Print) Linking ISSN: 2397768X NLM ISO Abbreviation: NPJ Precis Oncol Subsets: PubMed not MEDLINE

Mediastinal Malignant Melanoma Markedly Shrinking in Response to Nivolumab.

Authors: Sakaguchi H Tanimoto A Sato S et al.

Source: Internal medicine (Tokyo, Japan) [Intern Med] 2022 Jan 01; Vol. 61 (1), pp. 75-79. Date of Electronic Publication: 2021 Jun 26.

Publication Type: Case Reports; Journal Article

Journal Info: Publisher: Japanese Society of Internal Medicine Country of Publication: Japan NLM ID: 9204241 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1349-7235 (Electronic) Linking ISSN: 09182918 NLM ISO Abbreviation: Intern Med Subsets: MEDLINE

Combined PARP and PD-L1 inhibition: a promising treatment option for relapsed small-cell lung cancer.

Authors: Yanagimura N Watanabe S Kikuchi T

Source: Journal of thoracic disease [J Thorac Dis] 2024 Jun 30; Vol. 16 (6), pp. 4075-4078. Date of Electronic Publication: 2024 Jun 25.

Publication Type: Editorial; Comment

Journal Info: Publisher: AME Publishing Company Country of Publication: China NLM ID: 101533916 Publication Model: Print-Electronic Cited Medium: Print ISSN: 2072-1439 (Print) Linking ISSN: 20721439 NLM ISO Abbreviation: J Thorac Dis Subsets: PubMed not MEDLINE

Multi-institutional survey of cancer disparities in disabled patients in the region of northwestern Japan.

Authors: Sato S Tanimoto A Yanagimura N et al.

Source: International journal of clinical oncology [Int J Clin Oncol] 2021 Jun; Vol. 26 (6), pp. 1009-1014. Date of Electronic Publication: 2021 Mar 01.

Publication Type: Journal Article

Journal Info: Publisher: Springer-Verlag Tokyo Country of Publication: Japan NLM ID: 9616295 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1437-7772 (Electronic) Linking ISSN: 13419625 NLM ISO Abbreviation: Int J Clin Oncol Subsets: MEDLINE; PubMed not MEDLINE

Reduced doses of dabrafenib and trametinib combination therapy for BRAF V600E-mutant non-small cell lung cancer prevent rhabdomyolysis and maintain tumor shrinkage: a case report.

Authors: Adachi Y Yanagimura N Suzuki C et al.

Source: BMC cancer [BMC Cancer] 2020 Feb 24; Vol. 20 (1), pp. 156. Date of Electronic Publication: 2020 Feb 24.

Publication Type: Case Reports; Journal Article

Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407 (Electronic) Linking ISSN: 14712407 NLM ISO Abbreviation: BMC Cancer Subsets: MEDLINE

Patient-derived xenograft models of non-small cell lung cancer for evaluating targeted drug sensitivity and resistance.

Authors: Kita K Fukuda K Takahashi H et al.

Source: Cancer science [Cancer Sci] 2019 Oct; Vol. 110 (10), pp. 3215-3224.

Publication Type: Journal Article

Journal Info: Publisher: Wiley Publishing on behalf of the Japanese Cancer Association Country of Publication: England NLM ID: 101168776 Publication Model: Print Cited Medium: Internet ISSN: 1349-7006 (Electronic) Linking ISSN: 13479032 NLM ISO Abbreviation: Cancer Sci Subsets: MEDLINE

Phase II Trial of the Combination of Alectinib with Bevacizumab in Alectinib Refractory ALK-Positive Nonsquamous Non-Small-Cell Lung Cancer (NLCTG1501).

Authors: Watanabe S Sakai K Matsumoto N et al.

Source: Cancers [Cancers (Basel)] 2022 Dec 29; Vol. 15 (1). Date of Electronic Publication: 2022 Dec 29.

Publication Type: Journal Article

Journal Info: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101526829 Publication Model: Electronic Cited Medium: Print ISSN: 2072-6694 (Print) Linking ISSN: 20726694 NLM ISO Abbreviation: Cancers (Basel) Subsets: PubMed not MEDLINE

Efficacy and safety of amrubicin therapy after chemoimmunotherapy in small cell lung cancer patients.

Authors: Kushiro K Watanabe S Goto Y et al.

Source: Translational lung cancer research [Transl Lung Cancer Res] 2022 Sep; Vol. 11 (9), pp. 1858-1865.

Publication Type: Journal Article

Journal Info: Publisher: Pioneer Bioscience Publishing Company Country of Publication: China NLM ID: 101646875 Publication Model: Print Cited Medium: Print ISSN: 2218-6751 (Print) Linking ISSN: 22186751 NLM ISO Abbreviation: Transl Lung Cancer Res Subsets: PubMed not MEDLINE

Clinical outcome of patients with inoperable pancreatic cancer treated with FOLFIRINOX or gemcitabine plus Nab‑paclitaxel as a first‑line therapy: A retrospective analysis.

Authors: Sakaguchi H Tanimoto A Sato S et al.

Source: Medicine international [Med Int (Lond)] 2021 Jul 05; Vol. 1 (4), pp. 8. Date of Electronic Publication: 2021 Jul 05 (Print Publication: 2021).

Publication Type: Journal Article; Review

Journal Info: Publisher: Spandidos Publications Country of Publication: England NLM ID: 9918383867606676 Publication Model: eCollection Cited Medium: Internet ISSN: 2754-1304 (Electronic) Linking ISSN: 27541304 NLM ISO Abbreviation: Med Int (Lond) Subsets: PubMed not MEDLINE